Dinah Berkeley

Dinah Berkeley

Benzinga Editor

About
pronounced {DIE-nah}, they.them Dinah has been a writer with Benzinga since January of 2021. Currently, Dinah is writing primarily for cannabis and psychedelic companies in all markets from technologies to pharmaceuticals. Several of Dinah’s articl...
This Company is in the Business of People Betting on Themselves, and Winning Cash While Doing So
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. You know what they say: money's the motivation. 
Sponsored
The First Cannabinoid Company to be Part of Johnson & Johnson's Incubator JLABS is Readying for Pharmaceutical Distribution
Photo provided by Avicanna Inc. The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Sponsored
The New Wave in Cannabis Talent? One Company's Strategy to Support Enterprise MSOs
Image by David Gabric from Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Sponsored
How 2 Young Entrepreneurs Built Cannabis Delivery Software Tracking Millions in Cannabis Transactions Serving ⅓ of California's Cannabis Market
WebJoint Co-Founders: Christopher Dell’olio (L) and Hilart Abrahamian (R) The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Sponsored
Health is (Literally) Wealth: This App Gives You Cash for Your Workouts
Image by Paid Workout  The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Sponsored
Is This Company Taking a Think Tank Approach to the Hemp and CBD Industry?
Image by Kimzy Nanney on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Sponsored
How One Company Says It Aims To Demonstrate the Superiority of Psilocin Over Psilocybin in Treating Mental Health Conditions
Image by Mathew Schwartz from Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Sponsored
An Unstable Hiring Market? This Company Is Hoping To Combat Risk for its Clients in the Cannabis Industry
Image by David Gabrić from Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Image by David Gabrić from Unsplash
Sponsored
Equity vs. Debt in Cannabis: What's Better?
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The first move when starting many businesses is to decide between equity or debt financing. Read on for full-service business solutions provider Canna Business Resources (CBR) thoughts on the matter.
Sponsored
Establishing, Operating, and Leveraging A Global Platform with Canadian Cannabinoid Biopharma Co. Avicanna
Photo by Hakuna Matata on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Sponsored
SLANG Expands its Footprint and Launches Multiple Partnerships in Q3
Image from Brittany Hallett (SLANG Worldwide) The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Sponsored
POSaBIT Streamlines Going Digital for Cannabis Retailers
Image: Provided by POSaBIT The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Sponsored
Flora Growth Corp. Signs Letter of Intent to Export as Panama and Colombia Legalize Medical Cannabis Use
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Photo by Jeff W on Unsplash
Sponsored
How a Small Family Business is Becoming a Leader in the New York Cannabis Market
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Photo: Amy, Keeley, and Hillary Peckham
Sponsored
Canna Business Resources Provides Non-dilutive Capital for an Array of Unmet Needs
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Sponsored
CEO Ankur Rungta Speaks About C3's Thoughtful Strategy Toward Building a Sustainable MSO
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. At the Benzinga Cannabis Capital Conference in early June, David Feldman, Partner at Hiller PC and Skip Intro Advisors, interviewed C3’s CEO Ankur Rungta. 
Sponsored
Agrify Seeks to Stabilize the Risky Business of Growing Cannabis with its Smart Cultivation Software
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Image provided by Agrify
Sponsored
Nextleaf Focused on Owning The Largest Patent Portfolio for the Extraction, Distillation, and Delivery of Cannabinoids
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Sponsored
Aion Therapeutic Combines the Healing Powers of Cannabinoids and Psychedelics to Treat Cancer and Depression
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. To date, 74% of prescription drugs are derived from plants, 18% specifically from fungi. Still, many companies hesitate to invest in the medicinal benefits of mushrooms.
Sponsored
Mayo Clinic Purchases BioSig's PURE EP™ for use at its Phoenix Location
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Sponsored

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved